Sandra María
Sancho Martínez
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (4)
2022
2021
-
Urinary Plasminogen Activator Inhibitor-1: A Biomarker of Acute Tubular Injury
American Journal of Nephrology, Vol. 52, Núm. 9, pp. 714-724
2020
-
Combined use of GM2AP and TCP1-eta urinary levels predicts recovery from intrinsic acute kidney injury
Scientific Reports, Vol. 10, Núm. 1
-
Urinary TCP1-eta: A Cortical Damage Marker for the Pathophysiological Diagnosis and Prognosis of Acute Kidney Injury
Toxicological Sciences, Vol. 174, Núm. 1, pp. 3-15